🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don't miss this FREE webinar from our friends at the International Cancer Imaging Society! Prof Anwar Padhani & Prof Hashim Ahmed will explore the urological & radiological challenges when imaging the prostate. Anwar Padhani Hashim U. Ahmed Imperial Prostate 🔗 lnkd.in/gbWUz8f

AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study pubmed.ncbi.nlm.nih.gov/40016318/ This study aimed to validate the effectiveness of an artificial intelligence (AI) software, Pi, in detecting clinically significant #ProstateCancer (Gleason Grade Group

Pi™ (Prostate Intelligence™) achieved 95% sensitivity and 67% specificity, closely mirroring radiologists, illustrating how Pi could enhance the prostate MRI diagnostic pathway, addressing variability and expanding access to high-quality diagnostics. Read more here 👇

Pi™ (Prostate Intelligence™) was featured on BBC News! We're extremely proud to see PI being used within the NHS, helping to transform prostate cancer diagnosis with AI. The whole 10min film on prostate cancer starts at 30:05 lnkd.in/e6CNnmYw (Segment on Pi from 33:26)

Proud to join ProstateCancerResearch in championing prostate cancer screening through the #ProactiveForYourProstate campaign. Together, we’re advocating for early detection so we can save thousands of lives each year. Join us and help make screening a reality👉 mailchi.mp/pcr.org.uk/pro…

We had a great time at #BSUR2025 last week! It was good to see so many of you at our booth and at the symposium with Lucida Medical’s CEO, Dr Antony Rix. Thanks to everyone who stopped by, we enjoyed some really insightful conversations!

Lucida Medical is entering a new chapter, building on the same mission: advancing the prostate cancer pathway. We’re growing, innovating, and ready to show what’s next. Stay tuned!

We’re heading to #UKIO2025 in Liverpool, 2–4 June! Want to talk AI, imaging, or prostate cancer care? Book a meeting with our CEO, Dr Antony Rix: outlook.office.com/book/UKIO2025@…

𝐓𝐡𝐞 𝐜𝐨𝐮𝐧𝐭𝐝𝐨𝐰𝐧 𝐢𝐬 𝐨𝐧! The anticipation is building as we approach a major milestone for Lucida Medical. Our journey in advancing the prostate cancer pathway is about to reach an exciting new phase. Stay with us. The reveal is almost here!

What will the role of the GU radiologist look like in 2030? Join our Co-founder Prof. Evis Sala at the ESUR MRI Prostate Teaching Course, 12–14 June in Cambridge. Don’t miss her talk on Saturday 14 June at 17:10: “The GU Radiologist in 2030”. #ProstateCancer #Radiology #ESUR

🚀Big news! Lucida Medical has refreshed its brand identity, reinforcing our commitment to AI-powered prostate cancer care. This transformation strengthens our dedication to innovation and excellence in prostate cancer care. 🔗Learn more: lucidamedical.com/new-brand-iden…

Great first day at #BAUS25 in Manchester. 📍 We’re at Booth E20 sharing how our AI supports prostate cancer diagnostics. Come say hello. We're here for two more days. #ProstateCancer #MedicalInnovation

Our new logo tells a story. Two Ls form a star, symbolising clarity, direction and purpose. It reflects our mission to guide healthcare professionals through the complexity of prostate cancer care with confidence and precision. More than a mark, it’s a signal of who we are.

A compelling story in The i Paper shows how AI is improving cancer diagnosis in the NHS. Lucida Medical is featured for supporting prostate cancer detection. Dr Antony Rix, CEO: “We’ve trained AI to tell the difference between ‘nothing to worry about’ and ‘we need to act’.”